| Prevalence of flat lesions in a large screening population and their role in colonoscopy quality improvement K Reinhart, C Bannert, D Dunkler, P Salzl, M Trauner, F Renner, ... Endoscopy 45 (05), 350-356, 2013 | 1693 | 2013 |
| Bile salt transporters: molecular characterization, function, and regulation M Trauner, JL Boyer Physiological reviews 83 (2), 633-671, 2003 | 1275 | 2003 |
| Detection of various microplastics in human stool: a prospective case series P Schwabl, S Köppel, P Königshofer, T Bucsics, M Trauner, T Reiberger, ... Annals of internal medicine 171 (7), 453-457, 2019 | 1217 | 2019 |
| A placebo-controlled trial of obeticholic acid in primary biliary cholangitis F Nevens, P Andreone, G Mazzella, SI Strasser, C Bowlus, P Invernizzi, ... New England Journal of Medicine 375 (7), 631-643, 2016 | 1096 | 2016 |
| Molecular pathogenesis of cholestasis M Trauner, PJ Meier, JL Boyer New England Journal of Medicine 339 (17), 1217-1227, 1998 | 1079 | 1998 |
| Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) JM Banales, V Cardinale, G Carpino, M Marzioni, JB Andersen, ... Nature reviews Gastroenterology & hepatology 13 (5), 261-80, 2016 | 1070 | 2016 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1045 | 2019 |
| The interaction of hepatic lipid and glucose metabolism in liver diseases LP Bechmann, RA Hannivoort, G Gerken, GS Hotamisligil, M Trauner, ... Journal of hepatology 56 (4), 952-964, 2012 | 1025 | 2012 |
| Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA K Panzitt, MMO Tschernatsch, C Guelly, T Moustafa, M Stradner, ... Gastroenterology 132 (1), 330-342, 2007 | 904 | 2007 |
| Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series SF Lax, K Skok, P Zechner, HH Kessler, N Kaufmann, C Koelblinger, ... Annals of internal medicine 173 (5), 350-361, 2020 | 853 | 2020 |
| ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1 G Haemmerle, T Moustafa, G Woelkart, S Büttner, A Schmidt, ... Nature medicine 17 (9), 1076-1085, 2011 | 754 | 2011 |
| Bile acid receptors as targets for drug development FG Schaap, M Trauner, PLM Jansen Nature reviews Gastroenterology & hepatology 11 (1), 55-67, 2014 | 727 | 2014 |
| Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid GM Hirschfield, A Mason, V Luketic, K Lindor, SC Gordon, M Mayo, ... Gastroenterology 148 (4), 751-761. e8, 2015 | 678 | 2015 |
| Adipose triglyceride lipase contributes to cancer-associated cachexia SK Das, S Eder, S Schauer, C Diwoky, H Temmel, B Guertl, G Gorkiewicz, ... Science 333 (6039), 233-238, 2011 | 611 | 2011 |
| The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis M Trauner, M Arrese, CJ Soroka, M Ananthanarayanan, TA Koeppel, ... Gastroenterology 113 (1), 255-264, 1997 | 587 | 1997 |
| Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives JP Arab, SJ Karpen, PA Dawson, M Arrese, M Trauner Hepatology 65 (1), 350-362, 2017 | 578 | 2017 |
| New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond U Beuers, M Trauner, P Jansen, R Poupon Journal of hepatology 62 (1), S25-S37, 2015 | 576 | 2015 |
| Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice P Fickert, A Fuchsbichler, M Wagner, G Zollner, A Kaser, H Tilg, R Krause, ... Gastroenterology 127 (1), 261-274, 2004 | 547 | 2004 |
| Recent insights into the pathogenesis of nonalcoholic fatty liver disease JP Arab, M Arrese, M Trauner Annual Review of Pathology: Mechanisms of Disease 13, 321-350, 2018 | 541 | 2018 |
| Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis M Mandorfer, S Bota, P Schwabl, T Bucsics, N Pfisterer, M Kruzik, ... Gastroenterology 146 (7), 1680-1690. e1, 2014 | 475 | 2014 |
